TipRanks
Go Ultimate55% OFF

Peter C. Farrell Insider Profile

4 Followers

Peter C. Farrell, Director at Resmed, holds 51.80K shares in Resmed (Ticker: RMD), holds 98.70K shares in Arcturus Therapeutics (Ticker: ARCT), holds 53.17K shares in Evolus (Ticker: EOLS).

Peter C. Farrell's Trading History

RMD
Resmed
Sep 04, 2026DirectorUninformative Sell227.69K$11.91M
ARCT
Arcturus Therapeutics
Jun 18, 2024DirectorUninformative Buy97.06K$1.09M
EOLS
Evolus
Jan 31, 2023DirectorUninformative Buy―$390.83K
NUVA
NuVasive
Jun 15, 2015―Uninformative Buy―$1.46M

You May Also Like

Peter C. Farrell insider profile FAQ

What is the percentage of profitable transactions made by Peter C. Farrell?
The percentage of profitable transactions made by Peter C. Farrell is 40%.
What is the average return per transaction made by Peter C. Farrell?
The average return per transaction made by Peter C. Farrell is 48.10%.
What stocks does Peter C. Farrell hold?
Peter C. Farrell holds: RMD, ARCT, EOLS, NUVA stocks.
What was Peter C. Farrell’s latest transaction?
Peter C. Farrell’s latest transaction was an Uninformative Sell of $227.69K.
What was Peter C. Farrell's most profitable transaction?
Peter C. Farrell’s most profitable transaction was an Informative Buy of ARCT stock on August 21, 2019. The return on the trade was 507.60%.
What is Peter C. Farrell's role in Resmed?
Peter C. Farrell's role in Resmed is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.